Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 26.32% is 108% above its 5-year average of -319.41%, near the high end of its 5-year range (-13075.00%–91.35%).
106.01% above its 12-month average of -437.66%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): -604.63%.
GROSS MARGIN
26.32%
GROSS MARGIN AVG TTM
-437.66%
GROSS MARGIN AVG 3Y
-385.49%
GROSS MARGIN AVG 5Y
-319.41%
GROSS MARGIN AVG 10Y
-119.95%
GROSS MARGIN AVG 15Y
-27.06%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+106.01%
CURRENT VS 3Y AVG
+106.83%
CURRENT VS 5Y AVG
+108.24%
CURRENT VS 10Y AVG
+121.94%
CURRENT VS 15Y AVG
+197.28%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
43.48%
median of 452 covered companies
CURRENT VS SECTOR MEDIAN
-39.47%
vs the sector median at left
CollPlant Biotechnologies Ltd.
Market Cap
$4.42M
Gross Margin
26.32%
TTM Avg
-437.66%
3Y Avg
-385.49%
5Y Avg
-319.41%
Market Cap
$4.41M
Gross Margin
0.00%
TTM Avg
41.76%
3Y Avg
-40.89%
5Y Avg
-27.26%
Market Cap
$4.46M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.32M
Gross Margin
31.52%
TTM Avg
25.06%
3Y Avg
26.02%
5Y Avg
31.75%
Market Cap
$4.79M
Gross Margin
19.34%
TTM Avg
59.23%
3Y Avg
54.62%
5Y Avg
36.41%
Market Cap
$3.94M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
-19.05%
Market Cap
$4.96M
Gross Margin
77.68%
TTM Avg
77.66%
3Y Avg
77.69%
5Y Avg
77.69%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CollPlant Biotechnologies Ltd. (CLGN) | $4.42M | 26.32% | -437.66% | -385.49% | -319.41% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | 0.00% | 41.76% | -40.89% | -27.26% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.46M | 0.00% | 0.00% | 0.00% | 0.00% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | 31.52% | 25.06% | 26.02% | 31.75% |
| GRI Bio, Inc. (GRI)vs › | $4.18M | N/A | 0.00% | 0.00% | 0.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.79M | 19.34% | 59.23% | 54.62% | 36.41% |
| CalciMedica, Inc. (CALC)vs › | $4.85M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.94M | 0.00% | 0.00% | 25.00% | -19.05% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $4.96M | 77.68% | 77.66% | 77.69% | 77.69% |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.99M | 100.00% | 50.00% | 43.60% | 29.07% |
Gross Margin
26.3%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | -604.63% |
| 2026-03-31 | -332.88% |
| 2025-12-31 | -580.00% |
| 2025-09-30 | -538.96% |
| 2025-06-30 | -131.84% |
| 2025-03-31 | 78.98% |
| 2024-12-31 | -213.41% |
| 2024-09-30 | -13075.00% |
| 2024-06-30 | -220.08% |
| 2024-03-31 | -741.84% |
| 2023-12-31 | -253.51% |
| 2023-09-30 | -1179.07% |
| 2023-06-30 | 91.35% |
| 2023-03-31 | -39.72% |
| 2022-12-31 | -513.79% |
| 2022-09-30 | -400.00% |
| 2022-06-30 | -360.61% |
| 2022-03-31 | -310.61% |
| 2021-12-31 | -76.77% |
| 2021-09-30 | -98.65% |
| 2021-06-30 | 37.92% |
| 2021-03-31 | 93.89% |
| 2020-12-31 | 39.32% |
| 2020-09-30 | 65.26% |
| 2020-06-30 | 9.11% |
| 2020-03-31 | 22.00% |
| 2019-12-31 | 10.02% |
| 2019-09-30 | 5.01% |
| 2019-06-30 | 23.60% |
| 2019-03-31 | 31.82% |
| 2018-12-31 | 92.29% |
| 2018-09-30 | 36.33% |
| 2018-06-30 | 17.69% |
| 2018-03-31 | 51.44% |
| 2017-12-31 | 71.97% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | -38.57% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |